Clinical Trials Browser

Phase 2/3 × Unknown × Neoplasm Metastasis × Clear all

Neoplasm Metastasis

NCT03909724 2020-11-13

SUNRISE-CRC

Phase 2/3 Unknown

60 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT03491410 2018-04-09

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Phase 2/3 Unknown

60 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01782274 2017-10-12

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Phase 2/3 Unknown

60 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT01782287 2017-10-12

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Phase 2/3 Unknown

60 enrolled

CNSThoracic

Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT02208804 2016-11-09

SIM

Phase 2/3 Unknown

25 enrolled

Gastrointestinal

Digestive System Neoplasms, Liver Diseases, Neoplasm Metastasis, Colorectal Neoplasms

NCT01830231 2014-01-28

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

Phase 2/3 Unknown

372 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

Phase 2/3 Unknown

290 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

Clinical Trials

A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

SUNRISE-CRC

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

SIM

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection